IRI Separation Technologies Inc.
TSX VENTURE : IRI

IRI Separation Technologies Inc.

June 25, 2008 09:00 ET

IRI Separation Technologies Inc. Announces New President

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 25, 2008) - IRI Separation Technologies Inc. (TSX VENTURE:IRI) -

IRI Separation Technologies Inc. is pleased to announce that Ron Bayne will be assuming the role of Interim President of IRI. Mr. Bayne is currently the company's Chief Marketing Officer, and became involved with IRI in 2007 to oversee the company's marketing program. Mr. Rick Stiksma, the company's current President and CEO, as well as CFO, will be handing over the role of President to Ron, while retaining his position of CFO.

With 43 years of retail and packaged goods marketing, Mr. Bayne has developed and operated 8 retail drug chains. In addition, he has introduced over 300 private label goods including Health and Beauty Aids, Nutraceuticals, Vitamins and OTC's, to the market. He is a member of the CMO Council, an honor bestowed on only one percent of world marketers. His network stretches across all of Canada and throughout the Western USA, where he has contacts with a network of 50 affiliated broker sales agents covering 10 States including Alaska.

"I am pleased to see Ron move into the role of President. I believe his experience in leading companies taking products to market will be very helpful to IRI at this point in the company's history," said Rick Stiksma.

The Board is grateful to Rick for his work in the expanded role he took on during the last number of months. The company will do a search for a President and CEO in the near future.

IRI Separation Technologies Inc. (TSX VENTURE:IRI) is a biotechnology company that specializes in the extraction, development and commercialization of polyclonal antibodies for virus and bacteria related health issues. Intended for use as a nutraceutical for human consumption, the antibodies are derived from chicken eggs. The antibodies are intended for both the general and specific antibody market.

Forward Looking Statements: The above contains forward looking statements that are subject to a number of known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those anticipated in our forward looking statements. Factors that could cause such differences include: changes in world markets for nutraceuticals, equity market conditions, costs and supply of materials relevant to the nutraceutical industry, change in government and changes to regulations affecting the nutraceutical industry. Forward-looking statements in this release include statements regarding future store listings, operation plans, the MUNO® product launch, and the potential financing. Although we believe the expectations reflected in our forward looking statements are reasonable, results may vary, and we cannot guarantee future results, levels of activity, performance or achievements.

On Behalf of the Board of Directors - John Mason, Chairman

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information